Your browser doesn't support javascript.
loading
What's New in Genetic Skin Diseases.
Hill, Callie R; Theos, Amy.
Affiliation
  • Hill CR; University of Alabama at Birmingham School of Medicine, 1720 2nd Avenue South, Birmingham, AL 35294, USA.
  • Theos A; Department of Dermatology, University of Alabama at Birmingham, 1940 Elmer J. Bissell Road, Birmingham, AL 35243, USA. Electronic address: amy.theos@childrensal.org.
Dermatol Clin ; 37(2): 229-239, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30850045
ABSTRACT
The discoveries of new genes underlying genetic skin diseases have occurred at a rapid pace, supported by advances in DNA sequencing technologies. These discoveries have translated to an improved understanding of disease mechanisms at a molecular level and identified new therapeutic options based on molecular targets. This article highlights just a few of these recent discoveries for a diverse group of skin diseases, including tuberous sclerosis complex, ichthyoses, overgrowth syndromes, interferonopathies, and basal cell nevus syndrome, and how this has translated into novel targeted therapies and improved patient care.
Subject(s)
Skin Diseases, Genetic/diagnosis; Skin Diseases, Genetic/therapy; Autoimmune Diseases of the Nervous System/diagnosis; Autoimmune Diseases of the Nervous System/genetics; Autoimmune Diseases of the Nervous System/therapy; Basal Cell Nevus Syndrome/diagnosis; Basal Cell Nevus Syndrome/genetics; Basal Cell Nevus Syndrome/therapy; Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors; Dermabrasion; Dermatologic Agents/therapeutic use; Genetic Testing; Hereditary Autoinflammatory Diseases/diagnosis; Hereditary Autoinflammatory Diseases/genetics; Hereditary Autoinflammatory Diseases/therapy; High-Throughput Nucleotide Sequencing; Humans; Ichthyosiform Erythroderma, Congenital/diagnosis; Ichthyosiform Erythroderma, Congenital/genetics; Ichthyosiform Erythroderma, Congenital/therapy; Janus Kinase Inhibitors/therapeutic use; Laser Therapy; Lipoma/diagnosis; Lipoma/genetics; Lipoma/therapy; Molecular Diagnostic Techniques; Mosaicism; Musculoskeletal Abnormalities/diagnosis; Musculoskeletal Abnormalities/genetics; Musculoskeletal Abnormalities/therapy; Nervous System Malformations/diagnosis; Nervous System Malformations/genetics; Nervous System Malformations/therapy; Nevus/diagnosis; Nevus/genetics; Nevus/therapy; Pityriasis Rubra Pilaris/diagnosis; Pityriasis Rubra Pilaris/genetics; Pityriasis Rubra Pilaris/therapy; Protein Kinase Inhibitors/therapeutic use; Proteus Syndrome/diagnosis; Proteus Syndrome/genetics; Proteus Syndrome/therapy; Proto-Oncogene Proteins c-akt/antagonists & inhibitors; Sequence Analysis, DNA; Skin Diseases, Genetic/genetics; Sunscreening Agents/therapeutic use; TOR Serine-Threonine Kinases/antagonists & inhibitors; Tuberous Sclerosis/diagnosis; Tuberous Sclerosis/genetics; Tuberous Sclerosis/therapy; Ustekinumab/therapeutic use
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases, Genetic Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Dermatol Clin Year: 2019 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases, Genetic Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Dermatol Clin Year: 2019 Document type: Article Affiliation country: